Single Dose Escalation Study of P1101 in Healthy Adult Male Subjects
Status:
Completed
Trial end date:
2010-06-26
Target enrollment:
Participant gender:
Summary
This was a single-center, double-blind, randomized, active control, single dose escalation
study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD)
profiles of P1101 in 48 healthy volunteers.